ElleVet Sciences Names Top Veterinarians to Advisory Board

ElleVet Sciences has assembled some of the most experienced veterinary specialists and experts in the world to serve on a new advisory board and we’re delighted to announce that our own Dr Dave Tittle BVetMed GPCertVA (WVA&CPM), RCVS Advanced Practitioner in Veterinary Anaesthesia is included in this elite group.

The board will oversee ElleVet’s science-based research of its unique hemp cannabinoid products, which includes CBD + CBDA for dogs and cats. ElleVet Sciences was the first company to prove the safety and efficacy of its hemp-based CBD for pets.

These trusted advisors are not only well published and celebrated as leaders in the industry, but they also represent a number of different specialties and perspectives for ElleVet’s continued scientific interest in creating safe and effective products for your pets.

ElleVance is the UK based sister company of ElleVet, which is based in the USA. ElleVance is marketed in the UK as a human product. If you would like to discuss this further, please do not hesitate to contact us at Charter Vets.

A note from the Veterinary Medicines Directorate: 

As there are currently no CBD products authorised in the UK for veterinary use, a veterinary surgeon may prescribe a legally obtained human CBD product under the provisions of the prescribing cascade. Administration of an unauthorised product containing CBD without a veterinary prescription is an offence under Regulation 8 of the VMR. Companies supplying CBD products for human use in line with the requirements of the Medicines and Healthcare products Regulatory Agency must not indicate or recommend their products for use on animals.